title: Glucocorticoids in malignant lymphoid cells: gene regulation and the minimum receptor fragment for lysis.
abstract: We have examined clones of human malignant lymphoid cells for markers that correlate with glucocorticoid-mediated cell lysis. In glucocorticoid-sensitive clones of CEM, a human T-cell lymphoblastic leukemia line, two genes correlate with glucocorticoid-induced cell lysis. The glucocorticoid receptor (GR) itself is induced by standard glucocorticoids in sensitive clones and not in insensitive clones. The phenylpyrazolo-glucocorticoid cortivazol (CVZ) is capable of lysing several clones resistant to high concentrations of standard potent glucocorticoids. When these clones were tested for cortivazol responses, they were not only lysed by cortivazol but also showed induction of GR mRNA. Thus receptor induction appears to correlate with the lysis function of receptor in these cells. To determine what parts of the GR are required for lysis, we have mapped this function by transfecting and expressing GR and GR fragment genes in a GR-deficient CEM clone. Our results indicate that none of the known trans-activation regions of the GR are required. Removal of the steroid binding domain gives a fragment that is fully constitutive. Only one and one-half "Zn fingers" of the DNA binding region are required. We also find in CEM cells rapid suppression of the c-myc protooncogene, preceding growth arrest and cell lysis by glucocorticoids. This occurs only in clones possessing both intact receptors and lysis function. Thus the simple presence of GR alone is not sufficient to guarantee c-myc down-regulation. Introduction into the cells of c-myc driven by a promoter that does not permit suppression by glucocorticoids confers resistance to steroids. Furthermore, suppression of c-myc by antisense oligonucleotides also kills the cells. Therefore, c-myc appears to be a pivotal gene related both to ability of steroid to kill and to cell viability.
authors.affiliation: University of Texas Medical Branch, Galveston 77550.
authors.forename: E B
authors.initials: EB
authors.lastname: Thompson
authors.forename: L V
authors.initials: LV
authors.lastname: Nazareth
authors.forename: R
authors.initials: R
authors.lastname: Thulasi
authors.forename: J
authors.initials: J
authors.lastname: Ashraf
authors.forename: D
authors.initials: D
authors.lastname: Harbour
authors.forename: B H
authors.initials: BH
authors.lastname: Johnson
mesh_terms: D002460:Cell Line; D002872:Chromosome Deletion; D002999:Clone Cells; D003907:Dexamethasone / Q000494:pharmacology; D004351:Drug Resistance / Q000235:genetics; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D016259:Genes, myc; D005938:Glucocorticoids / Q000494:pharmacology; D006801:Humans; D008324:Mammary Tumor Virus, Mouse / Q000235:genetics; D008969:Molecular Sequence Data; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma; D011281:Pregnatrienes / Q000494:pharmacology*; D016271:Proto-Oncogene Proteins c-myc / Q000096:biosynthesis / Q000235:genetics; D012333:RNA, Messenger / Q000096:biosynthesis / Q000235:genetics; D011965:Receptors, Glucocorticoid / Q000187:drug effects / Q000235:genetics* / Q000378:metabolism; D011988:Receptors, Thyroid Hormone / Q000235:genetics; D014162:Transfection; D014222:Triamcinolone Acetonide / Q000494:pharmacology; D016335:Zinc Fingers / Q000235:genetics
chemical_list: D005938:Glucocorticoids; D011281:Pregnatrienes; D016271:Proto-Oncogene Proteins c-myc; D012333:RNA, Messenger; D011965:Receptors, Glucocorticoid; D011988:Receptors, Thyroid Hormone; D003907:Dexamethasone; D014222:Triamcinolone Acetonide; C005924:cortivazol